mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Majumder, Pradip K, Febbo, Phillip G, Bikoff, Rachel, Berger, Raanan, Xue, Qi, McMahon, Louis M, Manola, Judith, Brugarolas, James +5 more·2004·Nature Medicine
DOI 10.1038/nm1052

Cited by (962)

Items 901–962 of 962

  1. Metformin in Cancer Prevention and Therapy: New Application of an Old Drug
    Asmita Jain · 2017 · Journal of Medical Science And clinical Research
  2. Rapid estrogen signaling regulates PTEN: implications for cancer risk in steroid responsive tissues
    Melanie M. Scully · 2014
  3. A participação da via fosfatidilinositol3-quinase (PI3K)/mTOR no carcinoma epidermoide oral
    Andressa Duarte · 2018
  4. THE PROTEOSTASIS OF THE ENDOPLASMIC RETICULUM AND THE ACTIVATION OF THE UNFOLDED PROTEIN RESPONSE PATHWAY IN VIVO
    Luigina Tagliavacca · 2010 · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
  5. Clinicopathological Correlates of Pituitary Adenoma
    Eric Monsalves · 2015 · TSpace (University of Toronto)
  6. The Role of Nrf2 Signalling in Cell Proliferation and Tumorigenesis of Chromium Transformed Human Bronchial Epithelial Cells
    Marco Clementino · 2019 · UKnowledge (University of Kentucky)
  7. Investigating the role of amino acid transporter LAT3/SLC43A1 in prostate cancer
    Kun Zhang · 2019 · The Sydney eScholarship Repository (The University of Sydney)
  8. Evaluation of the therapeutic potential of Akt inhibition in a translational model of histiocytic sarcoma
    Qizhi Qin · 2018 · VTechWorks (Virginia Tech)
  9. Genotype-phenotype correlations in mouse musculoskeletal development and disease
    Alice Fiona Ford-Hutchinson · 2006 · Libraries and Cultural Resources (University of Calgary)
  10. Modeling human prostate cancer development using transgenic mice with heterogeneous mutations
    Jongchan Kim · 2009
  11. Prostate Cancer
    William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian · 2015 · Wiley eBooks
  12. AKT
    Matı́as Blaustein · 2017 · Springer eBooks
  13. PTEN
    Dawid Grzegorz Nowak, Lloyd C. Trotman · 2016 · Springer eBooks
  14. The Molecular Pathogenesis and Pathophysiology of Prostate Cancer
    William G. Nelson, Angelo Michael De Marzo · 2006 · Translational medicine series
  15. Can Biomarkers Increase R & D Productivity?
    2006 · Wiley eBooks
  16. Faculty Opinions recommendation of Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication.
    Grant McFadden · 2005 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  17. Faculty Opinions recommendation of Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
    Mark Robin Boothby · 2012 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  18. Supplementary References from Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
    Jonathan R. Dry, Sandra J. Pavey, Christine A. Pratilas, Chris G. Harbron, Sarah K. Runswick, Darren Hodgson, Christine M. Chresta, Rose McCormack, Natalie Byrne, Mark J. Cockerill et al. · 2023
  19. Data from CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
    Ning Zhao, Shalini Chopra, Kai R. Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran, Hyun Jung Kim, Jie Zhou, Shion An Lim, Kevin Leung et al. · 2023
  20. Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
    Andrew J. Armstrong, George Jabboure Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia A. Creel, Kelly Mundy, S. Lindsay Davis, Ting Wang, Roula Albadine et al. · 2023
  21. Data from The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
    Vesna Cerovac, Jose Luis Monteserin Garcia, Hadara Rubinfeld, Michael Buchfelder, Marco Losa, Tullio Florio, Marcelo Páez-Pereda, Günter Karl Stalla, Marily Theodoropoulou · 2023
  22. Supplementary Figure 3 from MYC Activity Mitigates Response to Rapamycin in Prostate Cancer through Eukaryotic Initiation Factor 4E–Binding Protein 1–Mediated Inhibition of Autophagy
    Bala S. Balakumaran, Alessandro Porrello, David S. Hsu, Wayne Glover, Adam Foye, Janet Y. Leung, Beth A. Sullivan, William C. Hahn, Massimo F. Loda, Phillip G. Febbo · 2023
  23. Supplementary Figure Legends 1-4, Methods from 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
    Nicolaos Jay Palaskas, Steven M. Larson, Nikolaus D. Schultz, Evangelia Komisopoulou, Justin Wong, Dan Rohle, Carl Campos, Nicolas A. Yannuzzi, Joseph R. Osborne, Irina Linkov et al. · 2023
  24. Data from Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
    Todd W. Miller, James T. Forbes, Chirayu Shah, Shelby K. Wyatt, H. Charles Manning, Maria Graciela Olivares, Violeta M. Sanchez, Teresa C. Dugger, Nara de Matos Granja, Archana Narasanna et al. · 2023
  25. Data from Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer
    Phillip G. Febbo, Aaron R. Thorner, Mark A. Rubin, Massimo F. Loda, Philip W. Kantoff, William K. Oh, Todd R. Golub, Daniel J. George · 2023
  26. Data from A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
    Andrew J. Armstrong, George Jabboure Netto, Michelle A. Rudek, Susan Halabi, David P. Wood, Patricia A. Creel, Kelly Mundy, S. Lindsay Davis, Ting Wang, Roula Albadine et al. · 2023
  27. Data from Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
    Chirayu Shah, Todd W. Miller, Shelby K. Wyatt, Eliot T. McKinley, Maria Graciela Olivares, Violeta M. Sanchez, Donald D. Nolting, Jason R. Buck, Ping Zhao, M. Sib Ansari et al. · 2023
  28. Data from Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
    Gunnar Johansson, Yonatan Y. Mahller, Margaret H. Collins, Mi‐Ok Kim, Takahiro Nobukuni, John Peter Perentesis, Timothy P. Cripe, Heidi A. Lane, Sara C. Kozma, GEORGE V. THOMAS et al. · 2023
  29. Data from Levels of p27 Sensitize to Dual PI3K/mTOR Inhibition
    Misu Lee, Marily Theodoropoulou, Jochen Graw, Federico Roncaroli, Maria Chiara Zatelli, Natalia Simona Pellegata · 2023
  30. Data from Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability
    Karl Xaver Knaup, Katrin Jozefowski, Regina Schmidt, Wanja M. Bernhardt, Alexander Weidemann, Jan Steffen Jürgensen, Christina Warnecke, Kai‐Uwe Eckardt, Michael Sean Wiesener · 2023
  31. Data from Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability
    Karl Xaver Knaup, Katrin Jozefowski, Regina Schmidt, Wanja M. Bernhardt, Alexander Weidemann, Jan Steffen Jürgensen, Christina Warnecke, Kai‐Uwe Eckardt, Michael Sean Wiesener · 2023
  32. Comprehensive pan-cancer analysis reveals the importance of SPATS2 in the development of hepatocellular carcinoma
    Jie Ding, Long Li, Wuhan Yu, Hong Deng, Lang Chen, Teng Fei Li, You Cheng Zhang · 2023 · Research Square
  33. Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
    Yentl Lambrechts, Sigrid Hatse, François Richard, Bram Boeckx, Giuseppe Floris, Christine Desmedt, Ann Smeets, Patrick Neven, Diether Lambrechts, Hans P. M. W. Wildiers · 2023 · Cancers
  34. Predictive etiology of Long COVID oncogenesis through SARS-CoV-2 proteins and AKT1 molecular docking interactions
    Rabia Nawaz, M. H. Qazi, Ammara Ahad, Muhammad Ali Arif, Muhammad Shahid, Irum Amin, Anum Ajmal, Aramish Naz, Urooj Irshad, Uqba Mehmood et al. · 2023 · Research Square
  35. Serum starvation induces density-dependent apoptosis via HIF-1 activation and JNK suppression
    Qifan Yang, Yaofeng Hu, Jiahui Lv, Jiaqi Xue, Jiaqi Chen, Changwan Wang, Fajian Hou · 2025 · Acta Biochimica et Biophysica Sinica
  36. Modeling Cancer Progression on the Pathway Level
    Elena J. Edelman · 2008 · DukeSpace (Duke University)
  37. Additional file 1 of MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin
    Yakun Luo, Virginie Vlaeminck‐Guillem, Silvère Baron, Sarah Dallel, Chang Xian Zhang, Muriel Le Romancer · 2021 · Figshare
  38. Additional file 2 of MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin
    Yakun Luo, Virginie Vlaeminck‐Guillem, Silvère Baron, Sarah Dallel, Chang Xian Zhang, Muriel Le Romancer · 2021 · Figshare
  39. Additional file 1 of The gene expression profile and cell of origin of canine peripheral T-cell lymphoma
    Eileen Owens, Lauren J. Harris, Adam Harris, Janna A. Yoshimoto, Burnett, Robert, Anne Avery · 2024 · Figshare
  40. Additional file 2 of The gene expression profile and cell of origin of canine peripheral T-cell lymphoma
    Eileen Owens, Lauren J. Harris, Adam Harris, Janna A. Yoshimoto, Burnett, Robert, Anne Avery · 2024 · Figshare
  41. Additional file 3 of The gene expression profile and cell of origin of canine peripheral T-cell lymphoma
    Eileen Owens, Lauren J. Harris, Adam Harris, Janna A. Yoshimoto, Burnett, Robert, Avery, Anne · 2024 · Figshare
  42. Lactylation Signatures as Predictors of Prognosis and Therapeutic Response in Lung Adenocarcinoma: Implications for Ultrasound-Based Therapeutic Strategies
    Qingchun Cai, Chenglu Huang, Y. Huang, Shi Bu, Zhiqiang Wang · 2026 · Cancer Biotherapy and Radiopharmaceuticals
  43. Cell-matrix mechanosensing and cellular metabolic demand are linked through SKT and mTORC2
    Milan Collins, Lorna E. Young, Emily Goodall, Beth Hammond, Daniel Newman, Paul Atherton, Patrick T. Caswell, Tobias Zech · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Outils biologiques pour l'exploration des réponses cellulaires à l'hypoxie dans les tumeurs mammaires invasives.
    Abderrahim El Guerrab · 2011 · theses.fr (ABES)
  45. Amino acids regulate hepatic intermediary metabolism-related gene expression via mTORC1-dependent manner in rainbow trout (Oncorhynchus mykiss)
    Dai Weiwei · 2015
  46. Analyse de l'activation de la voie PI3K/AKT dans le lymphome folliculaire
    Ouardia Imene Yahiaoui-Bentounsi · 2014
  47. Conditionnement ischémique à distance : Rôles du facteur de transcription induit par l’hypoxie-1α et de l’apolipoprotéine A1
    Hussein Kalakech · 2014
  48. PGC-1α régule un programme onco-métabolique capable de réprimer l’agressivité du cancer de la prostate
    Lisa Kaminski · 2018 · theses.fr (ABES)
  49. Role of VDAC1 hypoxic form, VDAC1-∆C, in the expression of primary cilia and tumor progression
    Lucilla Fabbri · 2019 · theses.fr (ABES)
  50. Implication de la GTPase RagA dans l’activation et la polarisation de la réponse lymphocytaire T
    Mehdi Attia · 2017
  51. Cellular and molecular mechanisms underlying the role played by the MEN1 gene in prostate cancer cells
    Yakun Luo · 2021 · theses.fr (ABES)
  52. Impact du ciblage du domaine de liaison de HIF-1α avec HIF-1β sur le paysage immunitaire du mélanome
    Audrey Lequeux · 2020 · theses.fr (ABES)
  53. Role of SF3B1 Mutations in Uveal Melanoma Oncogenesis
    Raquel Vivet-Noguer · 2021 · theses.fr (ABES)
  54. Role of hypoxia and metabolism in the maturation of hemodialysis arteriovenous fistulas
    Nirvana Sadaghianloo · 2018
  55. Rôle et ciblage de HIF-2a dans les gliomes de haut-grade pédiatrique de la ligne médiane
    Quentin Fuchs · 2022 · theses.fr (ABES)
  56. Effect of PI3K-p110α Inhibitor Alpelisib in the Differentiation and Effector Functions of M-CSF and GM-CSF Macrophages
    Cristina Villa-Gómez, Verónica Bermejo, Inmaculada Márquez-Leiva, Jana Baranda, Alejandro C. Briones, Isabel Cervera, Jordi Ochando, José María Rojo, Pilàr Portolés · 2026 · International Journal of Molecular Sciences
  57. Axin-2/BCL2 axis regulates apoptosis upon targeting TAM kinase
    Saba Naseem, Hussain Mustatab Wahedi, Afsar Ali Mian, Muhammad Asghar · 2026 · Research Square
  58. BindingDB Entry 50021279: Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors.
    BindingDB · 2009 · UC San Diego
  59. BindingDB Entry 50040848: Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    BindingDB · 2013 · UC San Diego
  60. BindingDB Entry 50003811: (Aryloxyacetylamino)benzoic acid analogues: A new class of hypoxia-inducible factor-1 inhibitors.
    BindingDB · 2020 · UC San Diego
  61. Mechanisms of NOTCH1 Mediated Leukemogenesis: A Dissertation
    Kathleen Cullion · 2009 · eScholarship@UMassChan
  62. Evaluation of Energetics-based Techniques for Proteome-Wide Studies of Protein-Ligand Binding Interactions
    M. Ariel Geer · 2015 · DukeSpace (Duke University)